Does the COMT Val108/158met Genotype Predict Cognitive Response to Antipsychotic Pharmacotherapy in Schizophrenia?

被引：0
|
作者：
Khan, Anzalee [1 ,2 ]
Lindenmayer, Jean-Pierre [1 ,3 ]
Kaushik, Saurabh [4 ]
Mortensen, Daniel [1 ,5 ]
Thanju, Amod [1 ]
Michaels, Timothy [1 ]
Jit, Raminer [1 ]
McGurk, Susan [6 ]
机构：
[1] Manhattan Psychiat Ctr, Psychopharmacol Res Program, Wards Isl, NY USA
[2] ProPhase LLC, Stat, New York, NY USA
[3] NYU, Sch Med, New York, NY USA
[4] St Josephs Hosp, Westchester, NY USA
[5] Columbia Univ, New York, NY USA
[6] Boston Univ, Boston, MA 02215 USA
来源：
BIOLOGICAL PSYCHIATRY | 2014年 / 75卷 / 09期
关键词：
COMT; Schizophrenia; Antipsychotics; Neurocognition;
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
195
引用
收藏
页码：61S / 61S
页数：1
相关论文
共 50 条
  • [1] COMT val108/158met genotype, cognitive function, and cognitive improvement with clozapine in schizophrenia
    Woodward, Neil D.
    Jayathilake, Karu
    Meltzer, Herbert Y.
    SCHIZOPHRENIA RESEARCH, 2007, 90 (1-3) : 86 - 96
  • [2] The relationship between MMN and COMT Val108/158Met genotype in schizophrenia
    Horikoshi, Sho
    Shiga, Tetsuya
    Hoshino, Hiroshi
    Ochiai, Haruka
    Kanno-Nozaki, Keiko
    Kanno, Kazuko
    Kaneko, Haruka
    Miura, Itaru
    Yabe, Hirooki
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2016, 19 : 211 - 211
  • [3] Association of COMT Val108/158Met genotype with smoking cessation
    Munafo, Marcus R.
    Johnstone, Elaine C.
    Guo, Boliang
    Murphy, Michael F. G.
    Aveyard, Paul
    PHARMACOGENETICS AND GENOMICS, 2008, 18 (02): : 121 - 128
  • [4] Antipsychotic medications and cognitive functioning in bipolar disorder: moderating effects of COMT Val108/158Met genotype
    Baer Arts
    Claudia JP Simons
    Marjan Drukker
    Jim van Os
    BMC Psychiatry, 13
  • [5] Effect of COMT Val108/158Met Genotype on Risk for Polydipsia in Chronic Patients with Schizophrenia
    Yamada, Kenji
    Shinkai, Takahiro
    Chen, Hsin-I
    Utsunomiya, Kensuke
    Nakamura, Jun
    NEUROMOLECULAR MEDICINE, 2014, 16 (02) : 398 - 404
  • [6] Effect of COMT Val108/158Met Genotype on Risk for Polydipsia in Chronic Patients with Schizophrenia
    Kenji Yamada
    Takahiro Shinkai
    Hsin-I Chen
    Kensuke Utsunomiya
    Jun Nakamura
    NeuroMolecular Medicine, 2014, 16 : 398 - 404
  • [7] Effect of Comt Val108/158Met Genotype on Different Executive Functions in Patients with Schizophrenia
    Berberian, Arthur A.
    Gadelha, Ary
    Christofolini, Denise M.
    Scarpato, Bruno S.
    Melaragno, Maria I.
    Mari, Jair J.
    Smith, Marilia A. C.
    Bressan, Rodrigo A.
    BIOLOGICAL PSYCHIATRY, 2010, 67 (09) : 79S - 79S
  • [8] Catechol-O-methyltransferase val108/158met genotype and response to antipsychotic medication in schizophrenia
    Illi, Ari
    Kampman, Olli
    Haenninen, Kari
    Anttila, Sami
    Mattila, Kari M.
    Katila, Heikki
    Rontu, Riikka
    Hurme, Mikko
    Lehtimaeki, Terho
    Leinonen, Esa
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2007, 22 (04) : 211 - 215
  • [9] Interaction of COMT Val108/158Met Genotype and Treatment-Resistance in Patients with Schizophrenia
    Gadelha, Ary
    Christofolini, Denise M.
    Rocha, Deyvis L.
    Nogueira, Sintia I.
    Bressan, Vania R.
    Bellucco, Fernanda T. S.
    Melaragno, Maria I. S. A.
    Mari, Jair J.
    Smith, Marilia A. C.
    Bresssan, Rodrigo A.
    BIOLOGICAL PSYCHIATRY, 2009, 65 (08) : 201S - 201S
  • [10] COMT Val108/158Met genotype modulates human sensory gating
    Majic, Tomislav
    Rentzsch, Johannes
    Gudlowski, Yehonala
    Ehrlich, Stefan
    Juckel, Georg
    Sander, Thomas
    Lang, Undine E.
    Winterer, Georg
    Gallinat, Juergen
    NEUROIMAGE, 2011, 55 (02) : 818 - 824
12345